Loading...

ONCOTELIC THERAPEUTICS INC Company Mergers 8-K Filing

NCTL

ONCOTELIC THERAPEUTICS INC

()

2026 8-K

Merger Announcement

Annual Results Update

Joint Development Agreement

Product Launch Announcement

Research Presentation

Financing Agreement

Stock Agreement Details

Milestone Amendment

Contract Amendment

Funding Agreement Completed

Debt Financing Agreement

Access to Research Tools

Investment Offering Details

Investor Presentation Update

Equity Offerings

Presentation Announcement

External Links:

On May 1, 2026, Oncotelic Therapeutics, Inc. completed a merger with Lunai Bioworks, involving a transfer of patents and intellectual property valued at $20 million, with Oncotelic receiving 62.5% of newly issued preferred shares.

AI Assistant

ONCOTELIC THERAPEUTICS INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.